Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis ...
Right before her adoption, Piper, a senior Yorkie, suffered liver failure. She was rushed to the ER and is now receiving the ...